Invention Grant
- Patent Title: Method for manufacturing calteridol
-
Application No.: US17193129Application Date: 2021-03-05
-
Publication No.: US11319294B2Publication Date: 2022-05-03
- Inventor: Jong Soo Lee , Dae Myoung Yun , Byuong Woo Lee
- Applicant: ENZYCHEM LIFESCIENCES CORPORATION
- Applicant Address: KR Chungcheongbuk-do
- Assignee: ENZYCHEM LIFESCIENCES CORPORATION
- Current Assignee: ENZYCHEM LIFESCIENCES CORPORATION
- Current Assignee Address: KR Chungcheongbuk-do
- Agency: Nath, Goldberg & Meyer
- Agent Joshua B. Goldberg; Tanya E. Harkins
- Priority: KR10-2020-0030266 20200311
- Main IPC: C07D257/02
- IPC: C07D257/02
Abstract:
It is disclosed a method for preparing calteridol used as MRI contrast agents. It provides a method for preparing calteridol comprising: obtaining teridol represented by the following Formula 2 by reacting gadoteridol represented by the following Formula 1 with decomplexing agent; and obtaining calteridol represented by the following Formula 3 by reacting calcium ion with teridol represented by following Formula 2.
Public/Granted literature
- US20210284614A1 METHOD FOR MANUFACTURING CALTERIDOL Public/Granted day:2021-09-16
Information query
